Katwin 6 Tablet contains Deflazacort 6mg, a synthetic glucocorticoid used for its potent anti-inflammatory and immunosuppressive properties. It is indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, and certain types of muscular dystrophy. Deflazacort works by modulating the immune response and reducing inflammation through inhibition of multiple inflammatory cytokines and mediators. This medication is often preferred due to its relatively favorable side effect profile compared to other corticosteroids, with a lower risk of weight gain and osteoporosis. Katwin 6 should be administered under strict medical supervision, with dosage tailored to the severity of the condition and patient response. Common side effects may include gastrointestinal discomfort, increased susceptibility to infections, hyperglycemia, and mood changes. Long-term use requires monitoring for adrenal suppression, bone density reduction, and ocular complications such as cataracts. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; tapering the dose gradually is recommended. Patients should inform their healthcare provider of any pre-existing conditions or concurrent medications to avoid potential drug interactions. Katwin 6 Tablet is a valuable therapeutic option for controlling inflammation and modulating immune activity in chronic diseases.